Monte Rosa Therapeutics Proposes Terms For $176 Million IPO (Pending:GLUE)

Monte Rosa Therapeutics has filed proposed terms for a $176 million IPO of its common stock. The firm is developing treatments for various widely prevalent cancer conditions.
Read More